Comparison of Pharmacokinetics of Long-Acting Local Analgesics: CPL-01, a Novel Extended-Release Ropivacaine, Demonstrates Consistent and Predictable Exposure Compared with Liposomal Bupivacaine.
Abstract
[BACKGROUND AND OBJECTIVE] There is a significant medical need for improved long-acting local anesthetics to decrease postsurgical pain and reduce postoperative opioid use. While ropivacaine is considered a safer local anesthetic than bupivacaine, no long-acting ropivacaine formulation is currently marketed. Available formulations of bupivacaine show inconsistent pharmacokinetics (PK) among different surgical models, and inconsistency in PK may lead to a reluctance to use the medication owing to fear of local anesthetic systemic toxicity (LAST) or unreliable efficacy. CPL-01 is a novel extended-release formulation of ropivacaine. This analysis used existing published literature to compare the PK of CPL-01 and liposomal bupivacaine (LB) across five surgical models.
[METHODS] Published results of LB PK were used to construct dose-normalized curves in total knee arthroscopy, hemorrhoidectomy, and bunionectomy after a 200 mg dose, which were compared with a 200 mg dose of CPL-01 in abdominoplasty, herniorrhaphy, and bunionectomy.
[RESULTS] The shape of the CPL-01 systemic concentration curves was consistent across multiple surgical models; however, in LB it was not. The median time to peak concentration (T) of CPL-01 was 8-12 h and the median T of LB varied from < 1 to 36 h. CPL-01 showed tighter ranges in average peak concentration (C) compared with average concentration (C) ratios (less "swing") throughout 72 h, suggesting a more predictable and consistent release over time compared with the biphasic release in LB, with two distinct T peaks.
[CONCLUSIONS] CPL-01 demonstrates a more predictable and consistent release of ropivacaine over time, in contrast to LB's erratic and biphasic release of bupivacaine. If approved, the predictability of CPL-01 PK may give physicians greater confidence in more consistent efficacy and less fear of inadvertent LAST.
[METHODS] Published results of LB PK were used to construct dose-normalized curves in total knee arthroscopy, hemorrhoidectomy, and bunionectomy after a 200 mg dose, which were compared with a 200 mg dose of CPL-01 in abdominoplasty, herniorrhaphy, and bunionectomy.
[RESULTS] The shape of the CPL-01 systemic concentration curves was consistent across multiple surgical models; however, in LB it was not. The median time to peak concentration (T) of CPL-01 was 8-12 h and the median T of LB varied from < 1 to 36 h. CPL-01 showed tighter ranges in average peak concentration (C) compared with average concentration (C) ratios (less "swing") throughout 72 h, suggesting a more predictable and consistent release over time compared with the biphasic release in LB, with two distinct T peaks.
[CONCLUSIONS] CPL-01 demonstrates a more predictable and consistent release of ropivacaine over time, in contrast to LB's erratic and biphasic release of bupivacaine. If approved, the predictability of CPL-01 PK may give physicians greater confidence in more consistent efficacy and less fear of inadvertent LAST.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | abdominoplasty
|
복부성형술 | dict | 1 | |
| 해부 | Liposomal Bupivacaine
|
scispacy | 1 | ||
| 해부 | long-acting ropivacaine
|
scispacy | 1 | ||
| 해부 | knee
|
scispacy | 1 | ||
| 합병증 | bunionectomy
|
scispacy | 1 | ||
| 약물 | Ropivacaine
|
C0073571
ropivacaine
|
scispacy | 1 | |
| 약물 | Bupivacaine
|
C0006400
bupivacaine
|
scispacy | 1 | |
| 약물 | extended-release
|
scispacy | 1 | ||
| 약물 | [BACKGROUND AND OBJECTIVE
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] CPL-01
|
scispacy | 1 | ||
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | toxicity
|
C0040539
Toxicity aspects
|
scispacy | 1 | |
| 기타 | CPL-01
|
scispacy | 1 |
MeSH Terms
Bupivacaine; Ropivacaine; Liposomes; Delayed-Action Preparations; Anesthetics, Local; Humans; Postoperative Pain; Amides; Dose-Response Relationship, Drug
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Ex Vivo and In Vivo Histological Evaluation of a 3-μm Wavelength, 40-μm Spot Size Fractional Laser System for Dermatology.
- Correspondence on "Lymphatic pathway remodeling in the supraumbilical region after abdominoplasty: A prospective cohort study".
- Sculpting Success-The TULUANHA: Modified TULUA Lipo-Abdominoplasty in Post-Bariatric Body Contouring.